Research graph
References from Racial and socioeconomic disparities in frailty burden among older women with metastatic breast cancer: A SEER-Medicare analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Breast cancer statistics, 2023
2023 · External reference
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008–2017 ESME cohort
10.1016/j.esmoop.2021.100114 · 2021 · External reference
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
10.1007/s00432-020-03184-z · 2020 · External reference
The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor–positive, human epidermal growth factor receptor 2–negative metastatic breast cancer: a population-based study in British Columbia from 2003 to 2013
10.1002/cncr.32631 · 2020 · External reference
How not to neglect the care of elderly breast cancer patients?
10.1016/j.breast.2011.03.003 · 2011 · External reference
Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology
2017 · External reference
The prevalence and outcomes of frailty in older cancer patients
2015 · External reference
Practical assessment and management of vulnerabilities in older patients receiving chemotherapy
10.1200/jco.2018.78.8687 · 2018 · External reference
Geriatric assessment improves prediction of surgical outcomes in older adults undergoing cancer surgery
2012 · External reference
Frailty in relation to the accumulation of deficits
10.1093/gerona/62.7.722 · 2007 · External reference
Frailty in elderly people
10.1016/s0140-6736(12)62167-9 · 2013 · External reference
Disparities in breast cancer and African ancestry: a global perspective
2022 · External reference
Disparities in cancer outcomes: perspectives and future directions
2021 · External reference
Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer
10.1038/s41523-023-00595-2 · 2023 · External reference
Disparities in receipt of 1-st line CDK4/6 inhibitors with endocrine therapy for treatment of hormone receptor positive, HER2 negative metastatic breast cancer in the real-world setting
10.1186/s13058-024-01902-w · 2024 · External reference
Race, breast cancer subtypes, and survival in the Carolina breast cancer study
10.1001/jama.295.21.2492 · 2006 · External reference
The impact of comorbidity on cancer and its treatment
2016 · External reference
Using claims data to predict dependency in activities of daily living as a proxy for frailty
10.1002/pds.3719 · 2015 · External reference
Socioeconomic status is associated with frailty: the Women’s Health and Aging Studies
10.1136/jech.2008.078428 · 2010 · External reference
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population
2002 · External reference
Controlling for frailty in pharmacoepidemiologic studies of older adults: validation of an existing Medicare claims-based algorithm
10.1097/ede.0000000000000833 · 2018 · External reference
Male-female wage differentials in urban labor markets
10.2307/2525981 · 1973 · External reference
Unconditional quantile regressions
10.3982/ecta6822 · 2009 · External reference
Disparities in disease presentation and treatment initiation for de novo metastatic breast cancer
10.1001/jamanetworkopen.2026.8908 · 2026 · External reference
Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial
2021 · External reference
Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study
10.1016/s0140-6736(21)01789-x · 2021 · External reference
Disparities in treatment delays among metastatic breast cancer patients: insights from nationwide electronic health records, 2011–2022
2025 · External reference
Racial and ethnic disparities in receipt of ERBB2-targeted therapy for breast cancer, 2010-2020
10.1001/jamanetworkopen.2025.8086 · 2025 · External reference
Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update
10.1200/jco.23.00933 · 2023 · External reference
Race, breast cancer subtypes, and survival in the Carolina breast cancer study
10.1001/jama.295.21.2492 · ExternalCitation · doi-reference
Racial and ethnic disparities in receipt of ERBB2-targeted therapy for breast cancer, 2010-2020
10.1001/jamanetworkopen.2025.8086 · ExternalCitation · doi-reference
Disparities in disease presentation and treatment initiation for de novo metastatic breast cancer
10.1001/jamanetworkopen.2026.8908 · ExternalCitation · doi-reference
The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor–positive, human epidermal growth factor receptor 2–negative metastatic breast cancer: a population-based study in British Columbia from 2003 to 2013
10.1002/cncr.32631 · ExternalCitation · doi-reference
Using claims data to predict dependency in activities of daily living as a proxy for frailty
10.1002/pds.3719 · ExternalCitation · doi-reference
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
10.1007/s00432-020-03184-z · ExternalCitation · doi-reference
How not to neglect the care of elderly breast cancer patients?
10.1016/j.breast.2011.03.003 · ExternalCitation · doi-reference
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008–2017 ESME cohort
10.1016/j.esmoop.2021.100114 · ExternalCitation · doi-reference
Frailty in elderly people
10.1016/s0140-6736(12)62167-9 · ExternalCitation · doi-reference
Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study
10.1016/s0140-6736(21)01789-x · ExternalCitation · doi-reference
Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer
10.1038/s41523-023-00595-2 · ExternalCitation · doi-reference
Frailty in relation to the accumulation of deficits
10.1093/gerona/62.7.722 · ExternalCitation · doi-reference
Controlling for frailty in pharmacoepidemiologic studies of older adults: validation of an existing Medicare claims-based algorithm
10.1097/ede.0000000000000833 · ExternalCitation · doi-reference
Socioeconomic status is associated with frailty: the Women’s Health and Aging Studies
10.1136/jech.2008.078428 · ExternalCitation · doi-reference
Disparities in receipt of 1-st line CDK4/6 inhibitors with endocrine therapy for treatment of hormone receptor positive, HER2 negative metastatic breast cancer in the real-world setting
10.1186/s13058-024-01902-w · ExternalCitation · doi-reference
Practical assessment and management of vulnerabilities in older patients receiving chemotherapy
10.1200/jco.2018.78.8687 · ExternalCitation · doi-reference
Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update
10.1200/jco.23.00933 · ExternalCitation · doi-reference
Male-female wage differentials in urban labor markets
10.2307/2525981 · ExternalCitation · doi-reference
Unconditional quantile regressions
10.3982/ecta6822 · ExternalCitation · doi-reference
